AtriCure Inc (FRA:A5I)
€ 30.4 +0.80 (+2.7%) Market Cap: 1.55 Bil Enterprise Value: 1.49 Bil PE Ratio: 0 PB Ratio: 3.60 GF Score: 78/100

Q1 2026 AtriCure Inc Earnings Call Transcript

May 05, 2026 / 08:30PM GMT
Release Date Price: €24.2
Operator

Good afternoon, and welcome to AtriCureâs first-quarter 2026 earnings conference call. This call is being recorded for replay purposes, and at this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session following prepared remarks from AtriCureâs management.

I would now like to turn the call over to Marissa Bych from the Gilmartin Group for a few introductory comments.

Marissa Bych
Gilmartin Group - Investor Relations

Great, thank you. By now, you should have received a copy of the earnings press release. If you have not received a copy, please call 513-644-4484 to have one emailed to you.

Before we begin today, let me remind you that the companyâs remarks include forward-looking statements. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond AtriCureâs control, including risks and uncertainties described from time to time in AtriCureâs SEC filings.

These statements include, but are not limited to, financial expectations and guidance,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot